TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands
Alexander Foss, Rebecca Haydock, Margaret Childs, Lelia M Duley, Theo Empeslidis, Sushma Dhar-Munshi, Alan A Montgomery, Reuben Ogollah, Mara Ozolins, Paul Tesha, Eleanor Mitchell
BMJ Open Ophthalmology Dec 2020, 5 (1) e000588; DOI: 10.1136/bmjophth-2020-000588